Skip to content
Politically.com Search all
Menu

2025 · 4th Quarter (Oct 1 - Dec 31)

SOLENO THERAPEUTICS, INC.

Filed by THE KPM GROUP DC LLC.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-08-03 06:26:15 UTC.

Source-reported fields

Filing overview

Type
4th Quarter - Report
Posted
Jan 15, 2026
Income
$50,000.00
Expenses
Not reported
Filing UUID
6cab09f7-9fb3-4ed6-8c37-d99e2358a3b8
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

HCR · Health Issues

H.R.946, Optimizing Research Progress Hope And New (ORPHAN) Cures Act H.R.1262/S.932, Give Kids a Chance Act H.R.1414, Camerons Law H.R.1509/S.752, Accelerating Kids Access to Care Act H.R.1492/S.832, EPIC Act S.527, Prescription Pricing for the People Act H.R.2450, Prescription Drug Transparency and Affordability Act S.882, Patients Before Middlemen Act S.526, Pharmacy Benefit Manager Transparency Act

Literal federal measure citations: H.R.946, H.R.1262, S.932, H.R.1414, H.R.1509, S.752, H.R.1492, S.832, S.527, H.R.2450, S.882, S.526

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.